Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial

Watchlist | Portfolio | Dashboard

Faster, Cleaner, Better.

Franklin Genomic Advancements ETF (HELX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] by (Cboe BZX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]

ETF Comparison for [[ item.sessionDateDisplayLong ]]

Results

Want to compare other data? Select Fields

Symbol	HELX
Company	Franklin Genomic Advancements ETF
Price Information
Exchange	NYSE Arca
Open	37.66
High	37.66
Low	37.21
Latest	37.21
Change	-0.52
% Change	-1.37%
Volume	2,900
20-Day Average Volume	2,695
Previous Close	37.73
Industry	N/A
Has Options	Yes
Technicals
20-Day Moving Average	36.35
20-Day Raw Stochastic	75.94%
20-Day Relative Strength	64.43
Weighted Alpha	+32.57
Today's Opinion	100% Buy
Previous Opinion	100% Buy
Last Month's Opinion	100% Buy
Performance
5-Days
%Chg	-2.22% since 11/28/25
Low	37.21 on 12/05/25
High	37.73 on 12/04/25
1-Month
%Chg	+6.41% since 11/05/25
Low	34.38 on 11/07/25
High	38.11 on 11/26/25
3-Month
%Chg	+21.52% since 09/05/25
Low	29.80 on 09/25/25
High	38.11 on 11/26/25
6-Month
%Chg	+39.89% since 06/05/25
Low	26.90 on 06/18/25
High	38.11 on 11/26/25
Key Statistics
Market Capitalization, $K	22,328
Shares Outstanding, K	600
Annual Sales	0
Annual Net Income	0
Last Quarter Sales	N/A
Last Quarter Net Income	N/A
60-Month Beta	1.06
Per-Share Information
Most Recent Earnings	N/A
Latest Earnings Date	N/A
Most Recent Dividend	0.004 on 12/30/21
Next Ex-Dividends Date	12/30/21
Ratios
Price/Earnings ttm	30.44